Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
No need for no Labs no more since the test are produce by Sigma-Aldrich, and them process and analyzed using the protocol of MRES in the lab chosen by the company who purchased them...
basically less cost and MORE profit!!!
very simple
No need for no Labs no more since the test are produce by Sigma-Aldrich, and them process and analyzed using the protocol of MRES in the lab chosen by the company who purchased them...
basically less cost and MORE profit!!!
GM In China in the News ( translation by Google below)
a nice read
GM: les ventes en Chine dépassent celles aux USA
DÉTROIT - Pour la première fois de son histoire, le constructeur automobile General Motors a vendu plus de véhicules en Chine qu'aux États-Unis l'an dernier.
Le géant de Détroit a vendu quelque 2,35 millions de voitures et de camions dans l'Empire du Milieu en 2010. C'est 136 000 de plus qu'en territoire américain.
Le nombre de véhicules vendus par GM en Chine a bondi de 29 pour cent, comparativement à 6,3 pour cent aux États-Unis.
À l'échelle mondiale, la croissance des ventes de GM s'est chiffrée à 12 pour cent.
Malgré ces gains spectaculaires, l'entreprise américaine n'a pas réussi à ravir à Toyota son titre de plus gros constructeur automobile du monde.
La société japonaise a en effet vendu 8,42 millions de véhicules l'an dernier, soit 30 000 de plus que GM.
Le géant américain s'attend à poursuivre sa croissance en 2011, entre autres grâce aux camionnettes qui sont particulièrement populaires auprès des PME. Ces dernières recommencent à investir après deux ans à se serrer la ceinture.
L'entreprise a d'ailleurs annoncé lundi qu'elle ajoutait un quart de travail à son usine de camionnettes de Flint, au Michigan, afin de répondre à la demande. Cela entraînera le rappel de 650 employés.
Les analystes de l'industrie pensent que la société pourrait reprendre la première place à Toyota dès cette année. Le constructeur japonais détient ce rang depuis 2008. Il avait auparavant toujours appartenu à GM.
GM sales in China exceed those in the U.S.
DETROIT - For the first time in its history, the automaker General Motors sold more vehicles in China that in the United States last year.
The Detroit giant has sold about 2.35 million cars and trucks in the Middle Kingdom in 2010. It's more than 136,000 U.S. territory.
The number of vehicles sold by GM in China jumped 29 percent, compared to 6.3 percent in the United States.
Globally, the growth of GM's sales amounted to 12 percent.
Despite these spectacular gains, the U.S. company failed to wrest from his Toyota as the biggest carmaker in the world.
The Japanese company has indeed sold 8.42 million vehicles last year, or 30,000 more than GM.
The U.S. giant expected to continue growing in 2011, partly thanks to vans that are particularly popular with SMEs. The latter will again invest after two years to tighten their belts.
The company also announced Monday that it added a shift at its truck plant in Flint, Mich., to meet demand. This will cause the recall of 650 employees.
Industry analysts believe the company could regain the top spot to Toyota this year. The Japanese manufacturer has this rank since 2008. He had previously been owned by GM.
UP UP IT GOES, 25% UP
UP UP IT GOES!!!!
LOOK I FIND THE RUSSIAN COMPANY PR!!!
http://news.rin.ru/news/280971/
18 ??????, 20:32
?????????? ???????? ?????-?? ??????????? ???????? ?? $275 ???
???????????? ???????: ?????????? ???????? ?????-?? ??????????? ???????? ?? $275 ???
??????? ?? ????: ?????????? ???????? ?????-?? ??????????? ???????? ?? $275 ??? ????????? ???? ??????? ??????? ??????? ?? 2006 ?.
?????????? ???????? ?????-?? ??????????? ???????? ?? ????????????? ???????? ?????????? ?????-????????????? ?????? ?? 275 ????????? ????????.
?????-?? ????????, ??? ????? ?????????? ??????????? ? ????????? Neuro-Biotech Corp (OTCQB-MRES), ?????????, ??????? ???????? ????? ?? ??????? ??????? ? ????????????? ? ????? ??????????, ????????????? ???????? ?? 10 ??? ?? ???????????? ????? ?? ??????????????? ??????????????? ???????? ????? Neuroceuticals? ?? ?????????? ?????????? ?????????. ????? ???? ?????-?? ???????? ?????????????? ????? ?? ?????????? ???????????? ? ???? ???????.
??? ??????????, ???????? ????? ????? ?????????? ?? ??????????? ?????? ??????? ? ????????? ? ???????? ????? ????????.
????????? ???? ?????? ????? ???????????? ?????????? ???????? ????????? ??????????????? ???????????, ???? ????? ????????? ??? ??????? ???????????.
???? ????? Neuroceuticals? ????? ???????? ????????? ???????? ?? ?????, ??? ????????? ???????? ?????????????????? "???? ? ??????", ??? ??? ?????? ?????????? ? ?????? ???????. ???? ??????? ?????????? ????? ????? ?? ? ?????? ????? ??????????????? ????????? ???????? ? ????????? ?????????? ???????.
???????????? ?????????? ???????? ????? Neuroceuticals? ????? ?????? ?????????? ????????? ????????, ??? ?????, ??? ????????? ? ?????????? ?????????????? ????????? ????????. ? ????????????? ? ?????????? ????? ??????, ???, ??????????, ???????? ? ????????????? ?????????? ?????????? ????, ? ??????? ???????? ?? ??????? ?? ????????????? ? ?????????????.
? ????????? ?????, ??? ????????? ?????, ??????????? ??????????, ?????????????????? ?? ?????? ???? ????????, ??????????? ?????????? ?????? ??????? "????????" ????????? ?? "??????".
? ?????????? Neuro-Biotech Corp
(www.neuro-biotechcorp.com)
???????? ??????? ? ????????? ? ?????? ????? (?????????). ???????? ???????????? ???????????? ???????? ???????? ??????????????? ???????????? ? ???????????? ????????????? ?????? ????? ??? ??????????? ?????? ??????? ? ?????????. ????????? Neuro-Biotech Corp ???????? ????????? ?? ?????? ?????????? ???????? ???????, ?? ? ?????? ????????? ???????? ? ???????????. ??????? ???? ?????????? ? ???? ???????????? ??????? ? ????????? ???????? ??? ??????? ?????????????? ???????? ???????? ? ?????????.
[?????? ??? ???????????] [?????????? ???????]
????????: news.rin.ru
??????????? ? ???????
http://news.rin.ru/news/280971/
OH MY GOD!!!! A 275 000 000 $ CONTRACT
YOU ARE RIGHT, THIS ONE IS GOING FAAAAR AWAY FROM THE SKY, LIKE IN OUTER-SPACE !!!!!
GO GO MRES !!!
AND UP 39% AGAIN!!!
cleaning all the INSIGNIFICANT loss...
The SKY on the horizon for UMNG
indeed,
and i wasn't aware that a 'dead' stock could go up LOLOL
Smart Scan Chart Analysis confirms that a strong uptrend is in place and that the market remains positive longer term. Strong Uptrend with money management stops. A triangle indicates the presence of a very strong trend that is being driven by strong forces and insiders.
Strong Uptrend Up
Based on a pre-defined weighted trend formula for chart analysis, MRES scored +100 on a scale from -100 (strong downtrend) to +100 (strong uptrend):
+10 Last Hour Close Above 5 Hour Moving Average
+15 New 3 Day High on Tuesday
+20 Last Price Above 20 Day Moving Average
+25 New 3 Week High, Week Ending January 22nd
+30 New 3 Month High in December
+100 Total Score
isnt that a nice way to come back from a long week end,
this week should be really great for us...
UP UP UP
GO MRES!!!
There is NO such thing as ILLEGAL shares, this thing just DOES NOT EXIST, the only thing that can be illegal about shares is the way they are being sold (Not Bought) ... like on those 2 example;
-Having the Restriction or Legend from shares (or Certificate) removed by Tricking the TA in some fraudulent or obscure ways, so they can be Cleared and ILLEGALLY Sold (because they weren't supposed to get cleared at that time).
-Or by NSS, witch is basically a sell of shares that the seller DOES NOT HAVE. But this is Legal or Tolerate in the Pink Sheets World if done by Market Makers.... but they have a period of time to buy them back and compensate the account.(but here again in the Pink Sheets they can play with that period of time by making it all around again)
So the share were NEVER Illegal, But the Selling of those shares WAS!
That is the only good question to ask, and the Pink Sheets site is not even saying it !!!
http://www.otcmarkets.com/stock/RCCH/company-info
so it s fair to think that more (or a lot more) have been sold...
According to the complaint, Gendarme Capital illegally distributed shares in 12 pink sheets companies starting in early 2008 and ending in May, 2010. Typically, Gendarme acquired shares from small public companies at a discount of 30 to 50 per cent, falsely representing to the issuer that it was buying the shares for investment purposes. Then, within days or weeks, Gendarme resold the stock on the market, the SEC says.
During the scheme, Gendarme claimed on its website that it was an accredited investor that bought shares under Rule 504, an exemption that applies to accredited investors who do not plan to resell the stock. According to the SEC, Gendarme actually bought the stock with a view to immediately selling it. In doing so, it acted as an underwriter and was required to register the transactions.
The other stocks listed in the complaint are Macada Inc., Perihelion Global Inc., Bederra Corp., Z Com Networks Inc., RCC Holdings Inc., 141 Capital Inc., RBID.com Inc., Russell Industries Inc. and TidwalWave Holdings Inc. (The complaint does not accuse the companies of any wrongdoing.)
http://www.stockwatch.com/News/Item.aspx?bid=Z-C:*SEC-1798053&symbol=*SEC&news_region=C
SEC charges pair for selling billions of shares
2011-01-06 19:41 ET - Street Wire
Also Street Wire (U-*SEC) U.S. Securities and Exchange Commission
Also Street Wire (U-BWNR) Brownstone Resources Inc
Also Street Wire (U-MGLG) Magellan Inc
by Mike Caswell
The U.S. Securities and Exchange Commission has filed civil charges against two U.S. residents for illegally distributing billions of shares in at least 12 pink sheets companies. The SEC claims that the men, Ezat Rahimi of California and Ian Lamphere of Vermont, repeatedly bought discounted shares in unregistered transactions and immediately dumped the stock, making $1.6-million in profits. (All figures are in U.S. dollars.) The stocks include Toronto-based Magellan Inc. and Toronto-based Brownstone Resources Inc.
The charges are contained a civil complaint the SEC filed on Jan. 6, 2011, in the Eastern District of California. In addition to Mr. Rahimi and Mr. Lamphere, the defendants are Cassandra Armento, a New York lawyer who wrote opinion letters used in the scheme, and Gendarme Capital Corp., a private company that Mr. Rahimi and Mr. Lamphere control.
According to the complaint, Gendarme Capital illegally distributed shares in 12 pink sheets companies starting in early 2008 and ending in May, 2010. Typically, Gendarme acquired shares from small public companies at a discount of 30 to 50 per cent, falsely representing to the issuer that it was buying the shares for investment purposes. Then, within days or weeks, Gendarme resold the stock on the market, the SEC says.
During the scheme, Gendarme claimed on its website that it was an accredited investor that bought shares under Rule 504, an exemption that applies to accredited investors who do not plan to resell the stock. According to the SEC, Gendarme actually bought the stock with a view to immediately selling it. In doing so, it acted as an underwriter and was required to register the transactions.
One example described by the SEC is that of WGL Entertainment Holdings Inc., a Florida-based company that produced a TV show called the WGL Million Dollar Shootout. Between March and September, 2008, Gendarme entered into warrant agreements that allowed it to buy shares of WGL at a 30-per-cent discount to the market price. The SEC says that Gendarme used those agreements to acquire over six billion shares for $615,000. According to the complaint, it then sold the stock within days or weeks, grossing $780,000. (The stock, which traded around two cents in March, 2008, was at 0.01 cent by October, 2008.)
In negotiating to buy the shares, Mr. Rahimi indicated to the company that he would help establish a market, the SEC claims. He told the CFO that Gendarme would "try to find a life in your stock" and "if your stock starts trading with our help, you will have a liquid stock on your hands."
One of the key helpers in the scheme, as described by the SEC, was Ms. Armento. According to the complaint, she drafted more than 50 opinion letters stating that Gendarme could receive shares in the companies without any trading restrictions. She made no inquiry as to whether Gendarme planned to sell the shares to the public, the SEC claims. "Armento knew that, as a result of her opinion letters, Gendarme was obtaining shares without a restrictive legend, and thus would have the ability to quickly sell the shares to the public, even if doing so violated ... the Securities Act," the complaint states.
The SEC is seeking appropriate civil penalties and disgorgement of ill-gotten gains against all defendants, as well as penny stock bans against all defendants except Ms. Armento.
The other stocks listed in the complaint are Macada Inc., Perihelion Global Inc., Bederra Corp., Z Com Networks Inc., RCC Holdings Inc., 141 Capital Inc., RBID.com Inc., Russell Industries Inc. and TidwalWave Holdings Inc. (The complaint does not accuse the companies of any wrongdoing.)
Magellan and Brownstone both list Canadian addresses, and one of the other stocks has a lesser Canadian connection. In 2009, RCC Holdings claimed that it had appointed William Hess, the former president of the Canadian Venture Exchange, as a director. (The company initially said he was president of the Toronto Stock Exchange, which it later corrected.) As it turned out, Mr. Hess did not ever become a director of the company, as his appointment was contingent on the company completing an acquisition that it never finalized.
Well UP 15% TODAY on some volume!!!
triple 0 far faaaaaar faaaaaaaaaaaaaaaaaar »FAAAAAR FFAAAAAAAAAAAAAAAAAAAAAAAAARRRRRRRRRRRRR
AAAWWWAAAAYYYYYYYYYY !!!!!
LOLOLOLOLOL
lol, yesterday it took 7 000 0000 to bring it back to 0.0007 and today, only 100 000 was enough for a drop at 0.0005...
i dont get it!
And it is important to remember that the market is still very slow, people are still on holiday or away. Next week when everybody will be back in front of their screen this Baby should Fly High !!!
GO MRES!!!
it hit the 0.0007 with 7 700 000 Volume,
Is there something we should know ?
or is there somebody that know something we dont ?
hmm....
well HRRN UP 50% so far !!!
not sure why, but still up!
UP UP UP !!!
A MOST SEE, ON FIRST PAGES AND P 8!!!!... OF LAB MEDIA INTERNATIONAL
PANEL OF BLOOD TEST... etc etc
THAT MRES ON THE FIRTS PAGE !! rest on page 8
http://www.mydigitalpublication.com/publication/?i=53799
that is the INTERNET version os a PAPER Newz Magazine, Made By Doctor FOR Doctor!!!
soooo GOOD
NO paid advertisement herE, Come on, in CHINESE IN CHINA, received where their is 0 investor or speculator (in hospital)... and NO TICKERS MENTIONED ..that is indeed a nice paid ad LOLOLOL
specially in a FROM DOCTOR TO DOCTOR newz magazine
FROM GOOGLE TRANSLATE Quantitative testing of blood-related diseases contribute to the diagnosis of Neuroscience
Publication of the _COM_GLOBAL_CURRENT_SITENAME
Posted on 14 Dec 2010
For in vitro diagnostic devices (IVDD) in the quantitative measurement of molecular nanotechnology could be the blood parameters, through specific biomarkers for assessment of brain neural input and output.
A reliable quantitative blood test 12 new combination products for general practitioners and specialists to provide diagnostic neuroscience-related disease or injury in the pathophysiology of clinical parameters required. This is the blood and other body fluids by identifying specific biomarkers of abnormal readings to achieve.
Blood tests will be used to detect, prevent, monitor and track the major social stress-related professional and occupational diseases. These include chronic fatigue syndrome (CFS), severe anxiety (GA), panic disorder (PS), neuropathy, or fibromyalgia (FM), some cardiovascular disease, Alzheimer's disease and Parkinson's disease and other neurological Tissue degenerative diseases, as well as depression and schizophrenia and other mental health disorders.
The product from the Neuro-Biotech Corporation (Basel, Switzerland, neuro-biotechcorp.com) development, is a non-invasive, sensitive, reliable and fast diagnostic test products out of the results. They will improve the existing clinical laboratory test procedures.
Neuro-Biotech companies in the clinical neuroscience expertise so that they can fully understand how the family of brain neurotransmitters in different ways under the influence of pituitary adrenal - sympathetic (HPAS) axis involved in the peripheral nervous system. HPAS conditioning shaft in response to pressure state of bodily functions and maintain homeostasis to the body by the immune and endocrine systems Psychoneuroimmunology against the psychological and social environment.
Related Links:
Neuro-Biotech Corp.>> Http://neuro-biotechcorp.com
http://china.labmedica.com/?option=com_article&Itemid=294732462&cat=%E5%85%8D%E7%96%AB%E5%AD%A6
Not sure what they are saying,
but its about MRES... this is the Web Version of a Magazine that they receive in all the Hospitals and Disease Research Centre...
Quantitative Blood Tests Help Diagnose Neuroscience-Related Diseases
By Labmedica International staff writers
Posted on 29 Sep 2010
Molecular nanotechnology is used in vitro diagnostic devices (IVDDs) for the quantitative measurement of blood parameters to evaluate the input and output of the brain through specific neuro-biomarkers.
A new, reliable portfolio of 12 quantitative blood tests will provide general practitioners and specialists clinical parameters for the diagnosis of neuroscience-related diseases or physiopathological impairments. This is accomplished by identifying abnormal readings of specific biomarkers within the blood or other biological fluids.
The blood tests are to be used for the detection, prevention, monitoring, and follow-up of the major stress-related, socioprofessional and occupational diseases. These include chronic fatigue syndrome (CFS), great anxiety (GA), panic syndrome (PS), neuropathies or fibromyalgia (FM), certain cardiovascular diseases, neurodegenerative diseases such as Alzheimer and Parkinson Diseases, as well as mental-health disorders such as depression and schizophrenia.
Developed by Neuro-Biotech Corp. (Basel, Switzerland), the diagnostic tests are noninvasive, sensitive, reliable, and produce rapid results. They will complement current clinical laboratory testing procedures.
Neuro-Biotech's expertise in clinical neurosciences applied enzymology is dedicated to the understanding of the relationship between the neurotransmitter families within the brain and their various influences on the peripheral systems involving the hypothalamopituitary adreno-sympathetic (HPAS) axis. The HPAS axis manages body mechanisms against stressful situations and maintains the homeostasis responsible for the resistance of the organism to its psycho-socio-environment through psycho-neuroimmune and endocrine systems.
Related Links:
Neuro-Biotech Corp.
http://labmedica.com/immunology/articles/294731350/quantitative_blood_tests_help_diagnose_neurosciencerelated_diseases.html
There is no RCMP no where , where you get that from, and revenu quebec
has nothing to do with MRES... In fact nor the AMF investigation, they are tracking Cortellazzi down!!!
dont mix everything
HA!!! i thought I got them, and was looking at my account settlement to confirm it, just to realize that NO, and was asking myself how come !!! Now I know why LOLOL !!! you got them !!!
Congrats! but next time I WILL !!!
have a good evening
The PPA (Prix Par Actions) is the french for PPS (Price Per Shares). He is probably just used to trade in french!
anyway Go GE, lets that PPS RISE!!!
it s great,
maybe missing a chart but beside that very nice and complete Ibox!!
MRES IS UP 1750% IN THE PAST 2 MONTH AND A HALF
PUUUUURE GOLD THAT IS !!!!
GO GO GO BAY GO AND FLY HIGH
MRES could GO BIG monday$$(must read) >>
-on july 27 MRES changed from a Mining Co to a MEDICAL company
http://finance.yahoo.com/news/NeuroBiote...
MRES has acquired a worldwide based biotechnological enterprise involved in the unique international niche of clinical neuroscience diagnostic testing. Neuro-Biotech's presently has the opportunity to market 12 clinical "Neuro Blood Tests" through partnerships.
http://neuro-biotechcorp.com/
http://finance.yahoo.com/news/NeuroBiote...
-New CEO Dr Claude Poulin Nominated as New CEO
he owns and operates a Lachute medical clinic where he continues to practice to this day
http://finance.yahoo.com/news/Mr-Claude-...
-new website is UP !!
http://neuro-biotechcorp.com/
important NOTE 1 :
One of the most noticeable differences between MRES and the other companies working in the field of Nanotechnology and Biotechnology is that we don't need to finance any further R&D (research and development), as this process has been completed during the past 30 years and our products have been tested according to standardized protocols in this domain. Therefore, R&D has been completed and the products are ready to be brought to the market. Some are already in the process of being ordered and negotiations are currently underway with several interested parties in various countries.
NOTE 2:MRES has first focused on SymPath(R) with
US patent (US 5879902) GRANTED IN 1999
article in Entrepreneur about patent :
Neuro-Biotech, Inc. (Sainte-Foy, Canada) has patented an in vitro diagnostic method for the determination of specific dopamine- beta -hydroxylase activity for the evaluation of the sympathetic nervous system function of a patient from a serum sample. (US 5879902)
http://savvy.entrepreneur.com/tradejourn...
about SymPath(R)
http://neuro-biotechcorp.com/en/site/dis...
the company was dormant and friday went into record volume
but on traders hands from Stockegg.com that profit taken Eod
more action is going to come with MRES
SEAB MM was buying crazy friday from traders
watch for action monday morning
http://messages.finance.yahoo.com/Stocks_%28A_to_Z%29/Stocks_N/threadview?m=tm&bn=78041&tid=29&mid=29&tof=1&frt=2
Exactly, MRES UP 1750% since October!!!
That is just GREAT and that s a FACT!!!
'' in a big way '' What a Joke that is!!!
nothing will happen, except for this BABY TO FLY of course !!!
lol
SMART SCAN CHART ANALYSIS
Received 5 min ago!
Smart Scan Chart Analysis continues positive longer term. Look for this market to remain firm. Strong Uptrend with money management stops. A triangle indicates the presence of a very strong trend that is being driven by strong forces and insiders.
Based on a pre-defined weighted trend formula for chart analysis, MRES scored +90 on a scale from -100 (strong downtrend) to +100 (strong uptrend):
-10 Last Hour Close Below 5 hour Moving Average
+15 New 3 Day High on Thursday
+20 Last Price Above 20 Day Moving Average
+25 New 3 Week High, Week Ending December 18th
+30 New 3 Month High in December
+90 Total Score
Gimme cheappies, GIMME CHEAPPIES !!!!
lol
yes indeed, Volume is Building, PPS is rising !!!
Next year will be, FANTASTIK !!
800 000 of Volume = NOT A LOT
in addition to that
Stock Teading 101 (very simple to understand)
405 000 of BUYING and only 350 000 of Sells ( 40 000 in between or known as Do NoT know or '?' )
Equal = NO DUMPING AT ALL!!!!!!
LOLOL
And if you add the 30% gain of yesterday...
NO Dump here!!!
tading 101
BUYS 403 000, SELLS 350 000
LOL